Is there a pAkt between VEGF and oral cancer cell migration?

• DOI: 10.1016/j.cellsig.2014.02.004
• Publication Date: 2014-02-19T19:47:11Z
• Authors: Mohammad R. Islam; Sarah J. Jones; Michaelina Macluskey; Ian R. Ellis
• Keywords: Vascular Endothelial Growth Factor A; 0301 basic medicine; 0303 health sciences; Pyridines; Oral cancer; Morpholines; pAkt; 610; Phosphoproteins; VEGF; 3. Good health; Phosphatidylinositol 3-Kinases; 03 medical and health sciences; Pyrimidines; Cell Movement; Chromones; Cell Line, Tumor; Carcinoma, Squamous Cell; Humans; Cell migration; Mouth Neoplasms; Phosphorylation; Furans; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt

The PI3K-Akt signalling pathway is a well-established driver of cancer progression. One key process promoted by Akt phosphorylation is tumour cell motility; however the mechanism of VEGF-induced Akt phosphorylation leading to motility remains poorly understood. Previously, we have shown that Akt phosphorylation induced by different factors causes both stimulation and inhibition of motility in different cell types. However, differential phosphorylation of Akt at T308 and S473 residues by VEGF and its role in head and neck cancer cell motility and progression is unknown. The cell lines investigated in this study exhibited a change in phosphorylation of Akt in response to VEGF. However, in terms of motility, VEGF stimulated oral cancer and its associated cell lines, but not normal keratinocytes or oral mucosal fibroblasts. The addition of a PI3 kinase and mTOR inhibitor, inhibited the phosphorylation of Akt and also effectively blocked VEGF-induced oral cancer cell motility, whereas only the PI3 kinase inhibitor blocked oral cancer associated fibroblast cell motility. This study therefore discloses that two different mechanisms of Akt phosphorylation control the motility potential of different cell lines. Akt phosphorylated at both residues controls oral cancer cell motility. Furthermore, immunohistochemical analysis of VEGF positive human head and neck tumour tissues showed a significant increase in Akt phosphorylation at the T308 residue, suggesting that pAkt T308 may be associated with tumour progression in vivo.